Showing results (321-330 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|July 12, 2022
From innovative thinking to pharmaceutical industry implementation: Some success storiesRosalind Walley, Nigel BrayshawPharmaceutical Statistics|July 12, 2022
Simulation-based sequential designPeter Müller, Yunshan Duan, Mauricio Garcia TecPharmaceutical Statistics|July 12, 2022
Study-design in pandemics: From surveillance and performance-evaluation to licensing and pharmacovigilanceSheila M BirdPharmaceutical Statistics|November 28, 2023
Propensity score-incorporated adaptive design approaches when incorporating real-world dataNelson Lu, Wei-Chen Chen, Heng Li, et al.Pharmaceutical Statistics|November 21, 2023
Inclusion of binary proxy variables in logistic regression improves treatment effect estimation in observational studies in the presence of binary unmeasured confounding variablesCornelius Rosenbaum, Qingzhao Yu, Sarah Buzhardt, et al.Pharmaceutical Statistics|November 8, 2023
An illness-death multistate model to implement delta adjustment and reference-based imputation with time-to-event endpointsAlberto García-Hernandez, Teresa Pérez, María Del Carmen Pardo, et al.Pharmaceutical Statistics|July 31, 2023
Type-I-error rate inflation in mixed models for repeated measures caused by ambiguous or incomplete model specificationsSebastian Häckl, Armin Koch, Florian LaschPharmaceutical Statistics|October 20, 2023
Group sequential design with maximin efficiency robust test for immunotherapy with generalized delayed treatment effectBosheng Li, Jingyi Zhang, Wenyun Yang, et al.Pharmaceutical Statistics|July 13, 2023
PubPredict: Prediction of progression and survival in oncology leveraging publications and early efficacy dataJianqi Zhang, Yufei Guo, Junyi Zhou, et al.Pharmaceutical Statistics|July 7, 2023
Modeling immunogenecity data to establish screening bioassays cut pointJorge Quiroz, Satrajit Roychoudhury, Thomas Steinmetz, et al.Pageof 119